Why copper peptides show up in skin and hair research
Two molecules dominate the copper-peptide literature, and they are easy to confuse because both are small, both carry a copper(II) ion and both arrive as the same striking blue powder. The full biochemistry — how GHK-Cu shifts the expression of thousands of genes — is the subject of our GHK-Cu copper-peptide reference. This page is the practical companion: where each one is actually studied (skin vs follicle), and how researchers handle concentration for topical versus in-vitro work.
The short version: GHK-Cu is the dermal-remodeling workhorse, and AHK-Cu is the follicle specialist. Choosing between them is mostly a question of which tissue your research model targets.
GHK-Cu and the skin data
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is the better-documented of the two for skin. In a double-blind, placebo-controlled study, Leyden et al. (Journal of Cosmetic Dermatology, 2018) reported measurable changes after 12 weeks of topical use — skin density up roughly 18%, elasticity up about 24%, and reduced wrinkle depth. In fibroblast culture the complex drives up to +70% type I/III collagen synthesis, and Hong et al. (Biogerontology, 2023) tied it to delayed fibroblast senescence through the p16/Rb pathway. These are research endpoints, not cosmetic promises — but they are why GHK-Cu is the copper peptide most associated with skin work.
AHK-Cu and the follicle
When the research question moves from skin to hair, AHK-Cu usually takes over. Swapping glycine for alanine changes the affinity profile: AHK-Cu is reported to bind hair-follicle dermal-papilla cells — the signaling hub of the follicle — more readily, which is why it appears in trichology and follicle-size studies. GHK-Cu is still present in that literature (follicle size, perifollicular matrix), so the two are typically compared rather than used in isolation.
| Copper peptide | Primary research focus | Reported angle |
|---|---|---|
| GHK-Cu | Skin, dermal remodeling | Collagen synthesis, gene regulation, elasticity |
| AHK-Cu | Hair / follicle | Dermal-papilla affinity, follicle research |
Topical vs in-vitro: getting the concentration right
This is where most handling mistakes happen, because the two contexts sit orders of magnitude apart. Topical research formulations are highly dilute — frequently well under 1% — because the copper complex is potent and light-sensitive. In-vitro work, by contrast, starts from a reconstituted stock and dilutes down to micromolar working concentrations.
The only equation you need is concentration = mass ÷ volume. Reconstitute with bacteriostatic water; the solution must stay clearly blue.
| Vial | Bacteriostatic water | Stock concentration |
|---|---|---|
| 50 mg | 5 mL | 10 mg/mL |
| 100 mg | 5 mL | 20 mg/mL |
| 100 mg | 2 mL | 50 mg/mL |
For the full step-by-step on solvent choice, sterile technique and storage windows, see the bacteriostatic water & reconstitution guide.
Sourcing identity-verified copper peptides
Because copper complexes degrade under light and heat, identity matters more than with simpler peptides. Look for >99% purity, a Certificate of Analysis from a named lab, mass-spec confirmation of the expected mass, and — visually — the characteristic blue powder that turns into a blue solution. The wider checklist on purity standards and COA reading lives in the complete research peptides guide.